Abstract:BACKGROUND: The chromodomain helicase/adenosine triphosphatase DNA binding protein 1-like gene (CHD1L) is a recently identified oncogene localized at 1q21. CHD1L protein over-expression in primary hepatocellular carcinoma is correlated with enhanced apoptosis inhibition, reduced chemosensitivity and shortened patient survival. However, CHD1L protein status or mRNA expression in breast cancer and its clinical significance remain obscure.MATERIAL AND METHODS: In this study, immunohistochemical staining for CHD1L expression was performed on tissue microarrays containing 179 primary invasive breast cancers and 65 matched normal breast tissue specimens. Clinico-pathological features were collected and compared between different CHD1L statuses. Kaplan-Meier curves were applied to estimate disease-free survival (DFS) and overall survival (OS). Cox regression was used to identify independent prognostic factors. Also, quantitative real-time polymerase chain reaction (QRT-PCR) was employed to evaluate the mRNA level expression of CHD1L in six breast cancer cell lines.RESULTS: Presence of CHD1L over-expression was observed in 87 of the 179 patients (48.6%), which associated with a younger age (P = 0.011), higher grade (P = 0.004), higher Ki-67 index (P = 0.018) and HER2 over-expression/amplification (P = 0.037). After a median follow-up of 55 months, patients with presence of CHD1L over-expression had significantly poorer DFS (82.6% Vs 76.3%, P = 0.035), but not OS (87.0% Vs 94.9%, P = 0.439). In multivariate analysis, CHD1L status (HR = 2.169, [95%CI, 1.029-4.573], P = 0.042), triple negative subtype (HR = 2.809, [95%CI 1.086-7.264], P = 0.033) and HER2 positive subtype (HR = 5.221, [95%CI 1.788-15.240], P = 0.002) were identified as independent prognostic factors for DFS. In vitro study indicated that relative mRNA expression level of CHD1L was higher in breast cancer cell lines, especially in MDA-MB-231 and LM2-4175, when compared to normal breast epithelial cell line.CONCLUSIONS: Presence of CHD1L over-expression is probably associated with aggressive tumor biology in breast cancer. CHD1L status might be a novel prognostic biomarker for patients with breast cancer.

Up-regulation of CHAF1A, a poor prognostic factor, facilitates cell proliferation of colon cancer.

CHI3L1 promotes proliferation and improves sensitivity to cetuximab in colon cancer cells by down-regulating p53.

Chromatin assembly factor 1, subunit A (P150) facilitates cell proliferation in human hepatocellular carcinoma.

Over-expression of CHAF1A in Epithelial Ovarian Cancer can promote cell proliferation and inhibit cell apoptosis.

High CHAF1A Expression Levels Are Positively-Correlated with PD-L1 Expression and Indicate Poor Prognosis in Gastric Cancer

CHAF1A Interacts with TCF4 to Promote Gastric Carcinogenesis Via Upregulation of C-Myc and CCND1 Expression.

Chac2, Downregulated in Gastric and Colorectal Cancers, Acted As A Tumor Suppressor Inducing Apoptosis and Autophagy Through Unfolded Protein Response

Chondroitin polymerizing factor promotes development and progression of colorectal cancer via facilitating transcription of VEGFB

Chd1l Promotes Tumor Progression and Predicts Survival in Colorectal Carcinoma

High FOXRED1 Expression Predicted Good Prognosis of Colorectal Cancer.

Overexpression of Chka Contributes to Tumor Progression and Metastasis and Predicts Poor Prognosis in Colorectal Carcinoma

High Expression of lncRNA AFAP1-AS1 Promotes the Progression of Colon Cancer and Predicts Poor Prognosis

Microrna-211 Expression Promotes Colorectal Cancer Cell Growth in Vitro and in Vivo by Targeting Tumor Suppressor Chd5

Long noncoding RNA AFAP1-AS1 facilitates tumor growth through enhancer of zeste homolog 2 in colorectal cancer.

The Expression and Clinical Value of CHAF1A in Hepatocellular Carcinoma

Long Non‐coding Ribonucleic Acid Zinc Finger Antisense 1 Promotes the Progression of Colonic Cancer by Modulating ZEB1 Expression

Identification of Chondroitin Polymerizing Factor (CHPF) As Tumor Promotor in Cholangiocarcinoma Through Regulating Cell Proliferation, Cell Apoptosis and Cell Migration

Histone Chaperone CHAF1A Impacts the Outcome of Fluoropyrimidines-Based Adjuvant Therapy in Gastric Cancer by Regulating the Expression of Thymidylate Synthetase.

Increased AOC1 Expression Promotes Cancer Progression in Colorectal Cancer

Presence of CHD1L Over-Expression Is Associated with Aggressive Tumor Biology and Is a Novel Prognostic Biomarker for Patient Survival in Human Breast Cancer

Upregulation of Long Noncoding RNA ZFAS1 Predicts Poor Prognosis and Prompts Invasion and Metastasis in Colorectal Cancer.